This inventor holds 5 USPTO granted patents and 2 published patent applications. Top assignees: Samsung Electronics Co., Ltd., Seoul National University, Korea Research Institute of Chemical Technology. Active years: 1998-2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
3 out of 132,108 
2 out of 1,791 
1 out of 655 
Years Active: 1998-2025
Title: Bong-Jin Lee: Innovator in Pharmaceutical Development
Introduction
Bong-Jin Lee is a prominent inventor based in Seoul, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative treatments for various health conditions. With a total of 5 patents to his name, Lee's work is recognized for its potential impact on medical science.
Latest Patents
Bong-Jin Lee's latest patents include groundbreaking inventions aimed at addressing critical health issues. One of his notable patents is an inhibitory material against human body-derived nicotinamide adenine dinucleotide phosphate-dependent steroid dehydrogenase-like. This invention serves as an anticancer agent and is effective in treating hyperlipidemia. The NSDHL inhibitor can overcome resistance to EGFR-targeting anticancer agents, showcasing its dual utility in cancer treatment and lipid management. Another significant patent involves a peptide targeting a toxin-antitoxin system, which can effectively induce cell death by separating the toxin from its complex without affecting the active site of the toxin. This antibiotic peptide holds promise as a composition against various bacterial infections.
Career Highlights
Bong-Jin Lee has had a distinguished career, working with leading organizations in the technology and academic sectors. He has been associated with Samsung Electronics Co., Ltd., where he contributed to innovative projects that bridge technology and healthcare. Additionally, his tenure at Seoul National University has allowed him to engage in cutting-edge research and development.
Collaborations
Throughout his career, Bong-Jin Lee has collaborated with notable colleagues, including Kyu-Yeon Lee and Sang Jae Lee. These partnerships have fostered a collaborative environment that enhances the innovation process and leads to the development of impactful solutions.
Conclusion
Bong-Jin Lee's contributions to pharmaceutical innovation highlight his role as a key inventor in the field. His patents reflect a commitment to advancing medical treatments and improving patient outcomes. Lee's work continues to inspire future innovations in healthcare.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile